Cyclo Therapeutics Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Cyclo Therapeutics stock had an average target of $0.95.

Price Target: $0.95 (+31.83%)

Analyst Consensus: Buy

Price Target

Target	Low	Average	Median	High
Price	$0.95	$0.95	n/a	$0.95
Change	+31.83%	+31.83%	n/a	+31.83%

Analyst Ratings

The average analyst rating for Cyclo Therapeutics stock from 3 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.

Recommendation Trends

No data available

Rating	Oct 2026
Strong Buy	n/a
Buy	n/a
Hold	n/a
Sell	n/a
Strong Sell	n/a
Total	n/a

Financial Forecast

Revenue This Year

985.66K

from 1.08M

-8.43%

from 1.08M

Revenue Next Year

1.23M

from 985.66K

24.49%

from 985.66K

EPS This Year

-0.69

from -1.23

EPS Next Year

-0.68

from -0.69

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025
Revenue	1.01M	903.38K	1.59M	1.38M	1.08M	985.66K	1.23M
Revenue Growth	-0.42%	-10.31%	75.54%	-13.24%	-21.76%	-8.43%	24.49%
EPS	-6.96	-5.59	-2.24	-1.83	-1.23	-0.69	-0.68
No. Analysts	-	-	-	-	-	5	5

Revenue Forecast

Revenue	2024	2025
High	1.3M	1.9M
Avg	985,656.6	1.2M
Low	560,560	496,860

Revenue Growth

Revenue Growth	2024	2025
High	17.1%	92.1%
Avg	-8.4%	24.5%
Low	-47.9%	-49.6%

EPS Forecast

EPS	2024	2025
High	-0.62	-0.53
Avg	-0.69	-0.68
Low	-0.75	-0.81

EPS Growth

EPS Growth	2024	2025
High	-	-
Avg	-	-
Low	-	-